Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet.

Hypocalcemia and an increase in creatinine level are the most important serious effects associated with foscarnet (PFA) therapy. In an animal model, we have explored the potential protective role of liposome-encapsulated foscarnet (LE-PFA) on these metabolic abnormalities. PFA administered as one bo...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Omar, R F, Dusserre, N, Désormeaux, A, Poulin, L, Tremblay, M, Beauchamp, D, Bergeron, M G
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1995
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162866/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8540701/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.9.1973
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!